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AbstrAct
Background Guidelines recommend primary care 
physicians (PCPs) offer patients a choice between 
colonoscopy and faecal immunochemical test (FIT) for 
colorectal cancer (CRC) screening. Patients choose almost 
evenly between both tests but in Switzerland, most 
are tested with colonoscopy while screening rates are 
low. A quality circle (QC) of PCPs is an ideal site to train 
physicians in shared decision-making (SDM) that will help 
more patients decide if they want to be tested and choose 
the test they prefer.
Objective Systematically assess CRC screening status of 
eligible 50–75 y.o. patients and through SDM increase the 
proportion of patients who have the opportunity to choose 
CRC screening and the test (FIT or colonoscopy).
Methods Working through four Plan-Do-Study-Act 
(PDSA) cycles in their QC, PCPs adapted tools for SDM and 
surmounted organisational barriers by involving practice 
assistants. Each PCP included 20, then 40 consecutive 
50–75 y.o. patients, repeatedly reported CRC status as 
well as the proportion of eligible patients with whom CRC 
screening could be discussed and patients’ decisions.
Results 9 PCPs initially included 176, then 320 patients. 
CRC screening status was routinely noted in the electronic 
medical record and CRC screening was implemented 
in daily routine, increasing eligible patients’ chance 
to be offered screening. Over a year, screening rates 
trended upwards, from 37% to 40% (p=0.46) and FIT use 
increased (2%–7%, p=0.008). Initially, 7/9 PCPs had no 
patient ever tested with FIT; after the intervention, only 2/8 
recorded no FIT tests.
Conclusions Through data-driven PDSA cycles and 
significant organisational changes, PCPs of a QC 
systematically collected data on CRC screening status 
and implemented SDM tools in their daily routine. This 
increased patients’ chance to discuss CRC screening. The 
more balanced use of FIT and colonoscopy suggests that 
patients’ values and preferences were better respected.
Problem
Primary care physicians (PCPs) do not 
usually offer their patients to make an 
informed choice on colorectal cancer (CRC) 
screening1 and patients might not have the 
opportunity to decide whether they want to 
be tested or how they would like to do so. 
Guidelines emphasise the importance of 
offering patients a choice between a struc-
tural examination like colonoscopy and a 
high-sensitivity stool-based test like faecal 
immunochemical test (FIT).2 3 When offered 
both options, patients divide almost evenly in 
their preferences.4 The large preponderance 
of colonoscopy in Switzerland5 6 suggests 
that PCPs in this country strongly prefer 
colonoscopy over FIT regardless of patient 
preferences.7 Consistent failure to offer FIT 
may contribute to low CRC screening rates in 
Switzerland.5 8
We designed this quality improvement 
(QI) project to encourage practice teams 
to implement systematic collection of CRC 
screening status and communication tools 
promoting shared decision-making (SDM) 
in CRC screening decisions. We conducted 
and tested the feasibility of data-driven 
PDSA cycles in a practice team and aimed to 
increase the proportion of patients eligible 
for CRC screening who could express their 
preference for or against testing and for FIT 
versus colonoscopy.
background
In Switzerland, screening colonoscopies and 
faecal occult blood tests (FOBTs) such as FIT 
are nationally reimbursed by the basic health 
insurance, for people aged 50–69 years. Access 
to colonoscopy varies by personal insurance 
plan. If patients are insured under a Health 
Maintenance Organisation plan, they need 
to be referred by their PCP. If insured with 
a flexible plan, patients have direct access 
to any specialists such as gastroenterologists 
but are typically referred by their PCP or by 
other involved specialists. Any specialist can 
prescribe FOBT, but because PCPs are the 
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coordinating healthcare professionals in Switzerland, 
they issue almost all the FOBT prescriptions.
CRC kills 1600 people each year and is the third most 
common cause of death from cancer in Switzerland. If 
screening with either colonoscopy or FIT begins at age 
50, the absolute risk of dying from CRC at age 80 can 
be halved.9 Colonoscopy is accurate but invasive, requires 
unpleasant preparations that begin the day before, and 
carries a small risk of serious adverse effects. FIT is conve-
nient, and the patient can take the sample at home. It 
can detect CRC as well as colonoscopy but may not iden-
tify as many polyps.10 Since these screening options have 
various benefits and harms with similar expected efficacy, 
this makes the choice of CRC screening methods a ‘pref-
erence sensitive’ situation in which physicians should 
accept their patient’s judgement about which test is better 
for them.11
SDM is an approach where clinicians and patients share 
the best available evidence when faced with the task of 
making decisions, and where patients are supported to 
consider options, to achieve informed preferences.11–13 If 
SDM was adopted by most Swiss PCPs to discuss CRC with 
their patients, it could increase the rate of patients getting 
the choice to be screened and reduce the discrepancy 
between patient’s preferences and prescribed methods 
for CRC screening. SDM is based on the assumption that 
the PCP is the person most trusted by the patients to 
help them consider and decide on a treatment path that 
accords with their values and needs.12 14 15
Changing PCPs’ routine so that most will offer patients 
the opportunity to be tested for CRC and the choice 
between screening tests poses a serious challenge, and 
the best place to address it may be in a quality circle 
(QC). QCs are groups of 6–12 healthcare professionals 
who meet regularly to reflect on their practice and realise 
multifaceted, step-based interventions for QI.16 17 80% 
of PCPs in Switzerland regularly attend QCs18 . QCs 
can use data-driven Plan-Do-Study-Act (PDSA) cycles to 
implement changes in their practices, especially if PCPs 
actively collect reliable data that inform their efforts.19 20 
QC participants create new concepts by combining practi-
tioner-based and evidence-based medical knowledge and 
test these new concepts to implement them into everyday 
practice.21 22
Practice assistants (PAs) can be deployed to help 
PCPs overcome organisational barriers to implementing 
systematic SDM for CRC screening. PAs are health profes-
sionals who carry out clinical and administrative tasks in 
PCP practices; they are common in Germany, the Nether-
lands, the USA and Switzerland.23 24 PAs might be able to 
take over some work of SDM, lowering the burden that it 
imposes on PCPs.25 26
measuremenT
To assist comprehension, please see online supplemen-
tary appendix 1. In collaboration with the PCPs of the 
QC, we developed and adjusted our data collection 
form, which allows PCPs to systematically and consecu-
tively collect data on 50–75 y.o. patients seen for more 
than 5 min in a non-urgent face-to-face consultation.5 6 To 
check consecutive enrolment, PCPs reported the number 
of weeks it took them to collect all the data. PCPs reported 
the patient’s age (birth year only), sex and previous CRC 
testing. We categorised previous CRC testing status as no 
previous testing, colonoscopy within the last 10 years, 
colonoscopy more than 10 years ago, FOBT within the 
past 2 years, FOBT more than 2 years ago, other tests 
and unknown. We collected data on any prior FOBT 
because FIT was introduced only 4 years ago in Switzer-
land; it was likely some patients were screened with other 
types of FOBT like the guaiac-based test. If patients had 
been tested within recommended intervals, PCPs did not 
need to collect more data. If patients had not been tested 
before or within recommended intervals, PCPs reported 
if patients had contraindications to CRC screening (life 
expectancy <5 years, current severe condition or other); 
if the patient had a contraindication, the PCP could 
stop collecting data. For eligible patients, PCPs reported 
whether they had discussed CRC. If they did not discuss it, 
they reported the reason: it was not appropriate to discuss 
screening during this visit; they had already discussed 
screening with the patient; or the patient had been seen 
during data collection or for another medical reason. If 
they discussed screening, PCPs reported the presence of 
potential symptoms of CRC (bloody stools, abdominal 
pain, weight loss, change in the bowel habits, others) and 
risk factors for CRC (personal history of CRC or polyps, 
family history of CRC or polyps, personal history of 
Crohn disease or ulcerative colitis or other). If the patient 
refused screening, the PCP noted the reason: no reason 
for refusal; patient does not feel concerned; patient fears 
side effects or complications; financial barriers; or other. 
Then, the PCP recorded the patient’s choice and the 
test they planned to take (no screening, colonoscopy, 
FOBT or other). In the second data collection, we added 
‘decision postponed’ to the choices to give patients the 
chance to think about it before making a decision. PCPs 
took their first measurement in March 2017 and included 
20 consecutive patients. They took their second measure-
ment in May 2018 and included 40 consecutive patients.
design
The long-lasting QC in Wil has been created 21 years ago 
and currently includes nine PCPs working in the same 
primary care office. One psychiatrist and one derma-
tologist working in the same office do not participate 
to the QC. The group consists of five senior and four 
younger physicians, five men and four women. They are 
employed by a large network providing primary health-
care. The patient population is mixed, rural and urban, 
as the practices serve a small city, surrounding villages 
and rural areas. Between January 2017 and May 2017, 
two clinician-researchers from the research team of the 
Institute of Primary Healthcare of Bern met with the QC’s 
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Figure 1 Study timeline.
participants in four QC meetings. PAs from the primary 
care office participated in the second part of the QI 
project lasting until September 2018. We describe these 
meetings in detail in the Strategy section and a timeline 
(see figure 1) offers an overview of the QI project. One 
PCP who moved to a different region did not participate 
to the second data collection.
sTraTegy
The research team helped the QC conduct overlapping 
PDSA cycles.
Pdsa cycle 1 (January 2017–march 2017)
This first PDSA cycle focused on updating existing inter-
vention material consisting in communication tools 
promoting SDM15 to suit QC’s specifications and values. In 
Switzerland, all citizens have healthcare coverage by law, 
but flexible deductibles are applied and can be as high as 
2500 Swiss franc (≈US$2500). The material presented at 
the first meeting had been developed for Canton Vaud’s 
organised CRC screening programme, which waives the 
deductible of the screening tests and the medical consul-
tation when a test is performed within the programme. 
Our study was conducted in Canton St Gallen, which has 
no organised screening programme and where costs of 
both tests are reimbursed, but deductible is not waived. 
The QC examined the communication tools which 
consisted in (1) a two-page structured evidence summary 
on CRC screening and information about colonoscopy 
and FIT, (2) a patient decision aid (20-page booklet) on 
CRC and (3) a four-page abridged version of the booklet 
to help PCPs discuss CRC screening with patients (‘Deci-
sion Board’).27 28 The QC also looked at a data collection 
form developed for this study by the research team.5 6 The 
PCPs studied and discussed the documents and suggested 
adaptations to better meet their specific needs. The 
research team updated the materials and data collection 
process accordingly.
Pdsa cycle 2 (January 2017–June 2017)
This second cycle was the core of the QI project. At the first 
QC meeting, the research team worked with QC partic-
ipants to identify and analyse current problems in CRC 
screening. The group acknowledged current literature on 
CRC and screening methods. PCPs accepted that screening 
rates were generally low and that PCPs' preferences for 
screening method is likely to have a disproportionate 
influence on the ratio of colonoscopy to FOBT. Partici-
pants then set out to change behaviour and use SDM to 
give their patients an opportunity to discuss CRC screening 
options. The group used the adapted material in role plays 
to improve their communication skills. The QC addressed 
organisational barriers by adjusting their electronic medical 
record (EMR) and coding patients’ CRC status as well as the 
performed test. In the next QC meeting, the group agreed 
that a data collection was necessary to quantitatively assess 
the current situation using the developed data collection 
form. The group decided that each PCP should collect data 
from 20 patients within a 4-week period, and they did this 
in March 2017. Then, the research group analysed the data 
and presented them to the PCPs at a fourth QC meeting. 
The PCPs said they had changed their behaviour and that 
it took less time to discuss screening with their patient than 
they had expected. They decided to further implement 
SDM and suggested they include PAs in the process because 
these showed interest during the first data collection and 
their involvement could increase the chance for patients to 
be screened for CRC.
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Pdsa cycle 3 (march 2017–may 2018)
In the third PDSA cycle, PCPs decided to involve PAs and 
delegate them CRC screening discussions with patients 
at average risk. PCPs decided to integrate CRC screening 
into the basic preventive care services the practice regu-
larly provide for patients aged over 50 y.o. In this practice, 
PAs regularly collect patients’ smoking status and system-
atically measure their body mass index (BMI), heart 
rate and blood pressure (BP). The PCPs conducted an 
internal pilot trial and involved two PAs in SDM about 
CRC screening options. During a session, the QC facili-
tator taught the PAs how to use the adapted SDM tools 
(the booklet intended to patients and the decision board 
to support discussions on screening). The PAs then prac-
tised by role playing. The PCPs implemented a rigorous 
process that identified high-risk patients; each morning 
before the consultations, PAs and PCPs briefly discussed 
the scheduled patients to assess to determine which of the 
50–75 y.o. ones were at increased risk for CRC (personal 
history, familial history or symptoms suggestive for CRC) 
and if those conditions precluded screening (eg, pres-
ence of malignancies or psychiatric diseases). The PCPs 
discussed screening options with high-risk patients, and 
the PAs discussed screening with all other eligible patients, 
if time allowed. If the PA identified CRC risk factors or 
symptoms during the discussion, the PCPs took over. If a 
patient opted for FIT, the PA supplied the necessary mate-
rial and information. If a patient opted for colonoscopy, 
the PCP performed a few medical tests and organised the 
referral to the gastroenterologist. After their discussion 
with eligible patients, PAs coded patient decisions: not 
willing/contraindication to screening; FIT; colonoscopy; 
or postponed decision. The new process was tested with 
two PAs for 2 weeks and then PCPs’ and PAs’ suggestions 
were integrated; for instance, they simplified the refer-
rals to gastroenterologists. The two PAs found this new 
process feasible and acceptable. They shared their expe-
riences with the whole PA team during a meeting led by 
the QC facilitator. Finally, all PCPs met with the two PAs 
to finalise details before the strategy was routinely imple-
mented.
Pdsa cycle 4 (June 2017–september 2018)
The fourth PDSA cycle evaluated PAs participation in the 
SDM process. All PCPs and all PAs were invited to a new 
QC meeting where the majority agreed that the whole 
team should implement the new process developed in 
PDSA cycle 3. The PCPs shared evidence and knowledge 
about CRC and screening with the PAs. They taught them 
the use of the information booklets and decision boards 
for SDM through role play. The QC facilitator along with 
the two PAs involved in the previous cycle presented the 
morning triage process, where eligible patients were 
identified. They also introduced electronic reporting 
of patients’ CRC status as follows: contraindications; 
chosen screening method; refusal or (in the second data 
collection round) postponed decision. The QC facili-
tator and the two PAs established routines to provide 
patients who chose FIT with information and sampling 
kits. Patients who chose colonoscopy had blood drawn to 
exclude a higher bleeding risk and were referred to the 
closest hospital. The PAs implemented the new process 
in their routine between January 2018 and April 2018. 
They discussed CRC screening with patients who were 
not at high risk whenever possible and used the EMR 
to report on patients’ CRC status, BMI, heart rate, BP 
and smoking status. Once this process was embedded 
in the PAs’ routine (April 2018), PAs and PCPs decided 
to conduct the second data collection. For this second 
data collection, the collection form was filled by PAs for 
non-high-risk patients, and by PCPs for the other ones. 
The research team met with all PAs at a supplementary 
meeting and explained how to use the data collection 
form.
resulTs
Pdsa cycle 1
PCPs suggested adapting the intervention documents, 
notably concerning information on reimbursement 
of screening tests in their canton, since St Gallen does 
not have an organised screening programme. They also 
changed the order of items on the data collection form 
so it better matched the order in which topics were raised 
by PCPs when they discussed CRC screening with their 
patients.
Pdsa cycle 2
PCPs implemented SDM in discussions about CRC 
screening options and continued to improve their 
communication techniques. They developed and imple-
mented an electronic coding algorithm ([0;1;2]: refusal/
contraindication; colonoscopy <10 years; FIT<2 years) 
that allowed them to reliably report CRC status. During 
the first data collection, the nine QC participants reported 
data on 20 consecutive patients (176 patients; one PCP 
only collected data on 16 patients). At baseline, screening 
rate was 37% (65/176) and almost all patients who were 
already up-to-date (colonoscopy ≤10 years or FOBT ≤2 
years) had been screened with colonoscopy (colonoscopy 
58/65; FOBT 3/65; other 4/65; see figure 2—Panel A). 
Of the nine PCPs, seven had no patients ever tested with 
FOBT (results not shown). PCPs could discuss screening 
options with most of the previously untested patients 
(55%–100%) who had not been excluded for contrain-
dications (figure 2—Panel B). After discussion, a quarter 
of patients refused screening. 63% opted for FIT and 
12% opted for colonoscopy (figure 2—Panel C). PCPs 
found they were able to discuss CRC screening with most 
eligible patients and it was much less time-consuming to 
diagnose patients’ preferences than they had expected. 
But because of some very high discussion rates (100%), 
the group agreed at a further QC meeting that PCPs 
could not be expected to discuss CRC screening with all 
eligible patient they saw.
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Figure 2 Panel A: CRC status at baseline in 2017 (n=176), 
Panel B: discussion rates for each PCP in 2017 (n=106), 
Panel C: decisions after discussion in 2017 (n=85). CRC, 
colorectal cancer; FOBT, faecal occult blood test; PCP, 
primary care physician.
Figure 3 Panel A: CRC status at baseline in 2018 (n=320), 
Panel B: discussion rates conducted by PAs and PCPs 
for each PCP in 2018 (n=171), Panel C: decisions after 
discussion in 2018 (n=111). CRC, colorectal cancer; FOBT, 
faecal occult blood test; PAs, practice assistants, PCP, 
primary care physician.
Pdsa cycle 3
Two PAs learnt to prepare the consultation agenda with 
PCPs so they could identify patients who were not at high 
risk, and then used the intervention material to facilitate 
SDM with these patients. They adapted them to suit their 
preferences and added the item ‘postponed decision’ to 
the data collection to capture this common choice. PAs 
learnt how to use the EMR to report a patient’s CRC 
status [(0;1;2;3): refusal/contraindication; colonoscopy 
<10 years; FIT <2 years; decision postponed). Finally, 
they learnt how to systematically assess CRC screening 
status and then discuss CRC screening with non-high-risk 
patients using SDM material.
Pdsa cycle 4
The team (24 PAs and 8 PCPs) participated in data collec-
tion and reported data on 40 consecutive patients for each 
PCP (320 patients). We show our main results in figure 3 
(panels A, B and C). Baseline screening rate increased 
from 37% to 40% but the increase was not statistically 
significant (p=0.46). The proportion of patients screened 
with FIT increased more than threefold (from 2% to 
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7%, p=0.008). The number of PCPs who had no patients 
tested with FOBT at baseline dropped to 2 of 8 (it was 
7/9 in 2017, results not shown). All but one PCP were 
able to discuss CRC screening with most of their eligible 
patients (42%–84%). Of patients with whom screening 
was discussed, 20% decided to postpone their decision 
and 80% made one (30% refused screening, 38% opted 
for FIT and 12% for colonoscopy).
Further results
 ► PAs added CRC status to routine collection of BMI, 
BP, and smoking status in EMR.
 ► PCPs developed routines for colonoscopy referrals 
that included sampling the patient’s blood, supplying 
detailed information about the test and giving the 
patient the necessary instructions for using laxative 
and dietary instructions.
lessons and limitations
When PCPs get the chance to choose what they want to 
address and can adapt the study material to do so, they 
actively get involved in the conception of a QI project. 
They are even able to overcome structural and organisa-
tional barriers such as patients’ triage for discussions on 
CRC screening, time restrains, delivery of quality infor-
mation and patient referrals.
Baseline screening rates tended to be higher over time 
(37% vs 40%) and the proportion of patients screened 
with FOBT increased more than threefold (from 2% to 
7%, p=0.008). The number of PCPs who had no patients 
tested with FOBT dropped from 7/9 in 2017 to 2 of 8 in 
2018. These results suggest that PCPs massively changed 
their prescription patterns for CRC screening while 
patients could better choose the option which best fitted 
their preferences.
When PCPs could discuss CRC screening, the vast 
majority of their patients took an active decision for CRC 
screening (for or against screening, and with which test). 
These results suggest the importance and relevance of 
offering patients a choice. When offered a choice, the 
proportion of patients who choose either colonoscopy or 
FOBT does not seem to match the proportion of colo-
noscopy screenings (89%) found in a recent Swiss study,5 
which suggests that PCP preferences overdetermine the 
choice of test.
We found that during first data collection (PDSA cycle 
2), some of the PCPs discussed screening with 100% of 
their eligible patients. They figured out, after discussing 
this point at a further QC meeting, that it was not prac-
tically feasible to do so in a real-life practice. This rate 
markedly decreased in the second data collection corre-
sponding to what seems to be routinely feasible and 
reasonable.
Consistent with the literature,29–31 participating PCPs 
found out that they needed to make substantial organ-
isational changes and involve PAs to implement SDM 
and facilitate discussions on CRC screening. PAs could 
significantly reduce PCP workloads25 26 by identifying and 
discussing CRC screening with non-high-risk patients, as 
well as reporting CRC status in the EMR.
The higher screening rates and substantial increase in 
the number of patients, who had been tested with FOBT 
after the second data collection, suggest that imple-
menting SDM increased the number of patients who were 
able to choose which test best suited their preferences 
and values. We are following up this pilot study with two 
randomised controlled trials in primary care practices32 33 
aimed at generating more evidence that training PCPs 
in SDM can decrease the variation in CRC test choice 
between PCPs and increase the variation in screening 
methods,15 and that this will ultimately raise screening 
rates. Our study has some limitations. Since we did not 
perform a chart-based validation of the data collected, we 
could not determine the accuracy of PCP self-reports and 
cannot rule out the possibility of selection bias in choice of 
participants by PCPs who might not always have followed 
the rule to include patients consecutively. During the first 
data collection some PCPs thought the goal was to discuss 
CRC screening with all eligible patients, which might have 
influenced and increased prescription rates (after discus-
sion) of the first results. In the second data collection, 
discussion rates decreased showing how PCPs and PAs 
integrated the notion that it was not feasible to discuss 
screening with all patients. Furthermore, our ability to 
compare the results of the first and second data collec-
tion is limited because PCPs alone collected the data in 
the first round, and PCPs and PAs both collected the data 
in the second round. Another point needs to be voiced as 
a limitation; although PCPs changed their practices after 
the intervention, screening rates at baseline need years 
to actually represent current prescription practices. The 
short observation time could explain the only moderate 
increase in screening rates at baseline between data 
collections. Finally, although the overall baseline testing 
rates and test proportions we found seem consistent with 
the literature,5 8 34 generalisation to practices in Switzer-
land is difficult due to the local context and the limited 
number of patients assessed in this pilot study.
Our study was strengthened by the use of a data collec-
tion form created by PCPs, who made sure it was clear 
and easy to integrate into their daily routine. Developing 
the implementation in a QI group allowed us to closely 
collaborate with PCPs, and allowed the PCPs to work 
together to make necessary modifications to the interven-
tion materials and the data collection form. This certainly 
enhanced an important sense of ownership among the 
participants regarding the study and its material. Further-
more, the study design offered PCPs to set convenient 
times for meetings, to improve data collection efficiency 
and PAs involvement as well as to implement changes to 
the EMR. Piloting the intervention as part of a pragmatic 
real-life study allowed us to test its suitability for imple-
mentation in primary care practices based on collection 
and analysis of reliable data collected through data-based 
QC with PDSA cycles. This participatory research study 
enabled durable changes by increasing acceptance of the 
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intervention by its participants. Furthermore, systematic 
report of CRC status in the EMR next to BMI, heart rate, 
BP and smoking status enables simple identification of 
patients not up-to-date with CRC screening on the long 
run and helps to ensure sustainability of this project.
PCPs are in a unique position to collect valuable data 
on discussion and refusal rates, which cannot be gath-
ered by other health care professionals, stakeholders, or 
insurance companies. Since QC participants could decide 
which aspects of quality of care are most important and 
how to improve them, our study presented an exceptional 
opportunity to measure what they are effectively doing to 
reach their goal.
conclusion
In this pilot QI project, characterised by data-driven 
PDSA cycles, a QC of PCPs routinely implemented 
systematic data collection on CRC screening status and 
communication tools promoting SDM in CRC screening 
decisions. Combining a multilevel training intervention 
with significant organisational changes such as involving 
PAs, the QC of PCPs successfully increased the chance for 
eligible patients to be offered to be screened for CRC and 
to choose between CRC screening options. The use of 
FIT increased more than threefold, which indicates that 
a higher proportion of patients might have been able to 
choose the test that best matched their preferences and 
values.
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